Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection

Current infection with Epstein-Barr virus, cytomegalovirus, hepatitis B virus, hepatitis C virus, or human immunodeficiency virus -1 and -2, autoantibodies (Table 1), and Helicobacter pylori antigen (tested in stool) were not detectable. (D) Course, platelet countAbbreviations: IVIG, intravenous imm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EJHaem 2021-08, Vol.2 (3), p.530-533
Hauptverfasser:	Furukawa, Yoshiki, Ando, Miki, Azusawa, Yoko, Kinoshita, Shintaro, Harada, Sakiko, Ochiai, Tomonori, Honda, Tadahiro, Sugimoto, Kazuya, Tabe, Yoko, Komatsu, Norio, Ando, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antigen-antibody complexes Antigens Autoantibodies Autoimmunity Blood platelets Bone marrow Case Report Case Reports Conflicts of interest Coronaviruses COVID-19 Cytokine storm Cytokines Cytomegalovirus Epstein-Barr virus Glycoprotein I Health aspects Helicobacter pylori Hepatitis Hepatitis B Hepatitis C HIV Human immunodeficiency virus Immune system Immunoassay Immunoglobulin G Immunoglobulin M Immunoglobulins Infections Intravenous administration Patients Platelets Purpura Purpura (Pathology) Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Sjogren's syndrome Steroids Stromal cells Thrombopoietin Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Current infection with Epstein-Barr virus, cytomegalovirus, hepatitis B virus, hepatitis C virus, or human immunodeficiency virus -1 and -2, autoantibodies (Table 1), and Helicobacter pylori antigen (tested in stool) were not detectable. (D) Course, platelet countAbbreviations: IVIG, intravenous immunoglobulin therapy; SARS-CoV-2, severe acute respiratory syndrome - coronavirus 2; SARS-CoV-2 IgG, anti-SARS-CoV-2 IgG-class antibody; SARS-CoV-2 IgM, anti-SARS-CoV-2 IgM-class antibody TABLE 1 Results, assays for infection and autoantibodies August 2020 March 2021 Agent HIV (-) (-) Hepatitis B virus (-) (-) Hepatitis C virus (-) (-) Epstein-Barr virus IgG: 160x, IgM < 10x, EBNA 160x IgG: 80x, IgM < 10x, EBNA 20x Cytomegalovirus (-) (-) Helicobacter pylori (-) Not assayed Autoantibodies Anti-nuclear (-) (-) Anti-SS-A (-) (-) Anti-SS-B (-) (-) Anti-DNA (IU/ml)
ISSN:	2688-6146 2688-6146
DOI:	10.1002/jha2.201